Amica Retiree Medical Trust’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,038
Closed -$196K 251
2019
Q4
$196K Sell
6,038
-1,341
-18% -$43.4K 0.15% 209
2019
Q3
$254K Hold
7,379
0.2% 151
2019
Q2
$252K Hold
7,379
0.21% 134
2019
Q1
$264K Hold
7,379
0.23% 113
2018
Q4
$237K Hold
7,379
0.23% 118
2018
Q3
$230K Hold
7,379
0.19% 144
2018
Q2
$224K Hold
7,379
0.2% 147
2018
Q1
$205K Hold
7,379
0.18% 159
2017
Q4
$207K Buy
+7,379
New +$212K 0.16% 173
2017
Q2
Sell
-7,644
Closed -$196K 355
2017
Q1
$196K Hold
7,644
0.16% 174
2016
Q4
$193K Buy
+7,644
New +$181K 0.15% 180
2016
Q3
Sell
-10,686
Closed -$277K 421
2016
Q2
$277K Hold
10,686
0.24% 120
2016
Q1
$273K Hold
10,686
0.23% 121
2015
Q4
$212K Hold
10,686
0.18% 155
2015
Q3
$226K Hold
10,686
0.2% 142
2015
Q2
$239K Hold
10,686
0.2% 147
2015
Q1
$256K Hold
10,686
0.22% 140
2014
Q4
$283K Hold
10,686
0.23% 129
2014
Q3
$260K Hold
10,686
0.22% 132
2014
Q2
$278K Hold
10,686
0.23% 129
2014
Q1
$256K Hold
10,686
0.22% 134
2013
Q4
$209K Buy
+10,686
New +$215K 0.18% 151

Other funds holding EXC

Amica Retiree Medical Trust's EXC Position: Q1 2020 in Review

Amica Retiree Medical Trust sold out of Exelon (EXC) in Q1 2020, closing a stake of 6,038 shares — an estimated $196K sold.

Amica Retiree Medical Trust first reported a position in EXC in Q4 2013 and held it in 22 quarters. The position peaked at $283K in Q4 2014. 881 funds tracked by Wall St. Rank hold EXC as of Q1 2020.

  • Amica Retiree Medical Trust reported no remaining Exelon position as of Q1 2020 after selling out during the quarter.
  • Amica Retiree Medical Trust sold 6,038 Exelon shares in Q1 2020, an estimated $196K.
  • Amica Retiree Medical Trust first reported a position in Exelon in Q4 2013 and held it in 22 quarters.
  • Amica Retiree Medical Trust's Exelon position peaked at $283K in Q4 2014.
  • 881 funds tracked by Wall St. Rank held Exelon as of Q1 2020.

Based on Amica Retiree Medical Trust's 13F filing for Q1 2020, filed 13 May 2020.